FDA Clearance Tracker · K893740
LIPIDIRECT LOW DENSITY LIPOPROTEIN CHOLESTEROL TES
Last checked: Nov 20, 2026Latest source record: Mar 19, 1990 (this decision)Source: openFDAMethods & limitations
Decided
Mar 19, 1990
Substantially Equivalent
Time to decision
306 days
Received May 17, 1989. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K893740
- Device name
- LIPIDIRECT LOW DENSITY LIPOPROTEIN CHOLESTEROL TES
- Applicant
- Reference Diagnostics, Inc.
- Applicant location
- Arlington, MA
- Received
- May 17, 1989
- Decided
- Mar 19, 1990
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- System, Test, Low Density, Lipoprotein (MRR)
- Device class
- Class I
- Regulation
- 21 CFR 862.1475
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code MRR (System, Test, Low Density, Lipoprotein).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Reference Diagnostics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.